Related references
Note: Only part of the references are listed.CD8+ T-cells of CLL-bearing mice acquire a transcriptional program of T-cell activation and exhaustion
Laura Llao Cid et al.
LEUKEMIA & LYMPHOMA (2020)
Circulating Extracellular Vesicles Induce Chimeric Antigen Receptor T Cell Dysfunction in Chronic Lymphocytic Leukemia (CLL)
Michelle J. Cox et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Pharmacological Inhibition of MALT1 Protease Leads to a Progressive IPEX-Like Pathology
Kea Martin et al.
FRONTIERS IN IMMUNOLOGY (2020)
Resistance-Associated Mutations in Chronic Lymphocytic Leukemia Patients Treated With Novel Agents
Lenka Sedlarikova et al.
FRONTIERS IN ONCOLOGY (2020)
CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells
Rebeca Arroyo Hornero et al.
COMMUNICATIONS BIOLOGY (2020)
Control of chronic lymphocytic leukemia development by clonally-expanded CD8+ T-cells that undergo functional exhaustion in secondary lymphoid tissues
Bola S. Hanna et al.
LEUKEMIA (2019)
Turning the Tide Against Regulatory T Cells
SeongJun Han et al.
FRONTIERS IN ONCOLOGY (2019)
Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells
Marc Rosenbaum et al.
NATURE COMMUNICATIONS (2019)
State-of-the-art for CAR T-cell therapy for chronic lymphocytic leukemia in 2019
Richard Lemal et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma
Hanjie Li et al.
CELL (2019)
Helios+ and Helios- Treg subpopulations are phenotypically and functionally distinct and express dissimilar TCR repertoires
Angela M. Thornton et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2019)
PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia
Bola S. Hanna et al.
LEUKEMIA (2019)
Dual PD1/LAG3 immune checkpoint blockade limits tumor development in a murine model of chronic lymphocytic leukemia
Marina Wierz et al.
BLOOD (2018)
Infections in patients with chronic lymphocytic leukaemia: Mitigating risk in the era of targeted therapies
Benjamin W. Teh et al.
BLOOD REVIEWS (2018)
Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients
Serena De Matteis et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Management of melanoma in patients with chronic lymphocytic leukemia
William J. Archibald et al.
LEUKEMIA RESEARCH (2018)
Chimeric Antigen Receptor Therapy
Carl H. June et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Single Cell T Cell Receptor Sequencing: Techniques and Future Challenges
Marco De Simone et al.
FRONTIERS IN IMMUNOLOGY (2018)
High-dimensional mass cytometry analysis revealed microenvironment complexity in chronic lymphocytic leukemia
Marina Wierz et al.
ONCOIMMUNOLOGY (2018)
T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
Marzia Palma et al.
HAEMATOLOGICA (2017)
T cells in chronic lymphocytic leukemia display dysregulated expression of immune checkpoints and activation markers
Marzia Palma et al.
HAEMATOLOGICA (2017)
Effector Regulatory T Cell Differentiation and Immune Homeostasis Depend on the Transcription Factor Myb
Sheila Dias et al.
IMMUNITY (2017)
Quantitative and qualitative analysis of regulatory T cells in B cell chronic lymphocytic leukemia
Vassiliki E. Mpakou et al.
LEUKEMIA RESEARCH (2017)
Tumor-infiltrating FoxP3+ Tregs predict favorable outcome in colorectal cancer patients: A meta-analysis
Guoming Hu et al.
ONCOTARGET (2017)
Regulatory T Cells and Their Prognostic Relevance in Hematologic Malignancies
Giovanni D'Arena et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2017)
MALT1 Inhibition Is Efficacious in Both Naive and Ibrutinib-Resistant Chronic Lymphocytic Leukemia
Nakhle S. Saba et al.
CANCER RESEARCH (2017)
Transient Treg depletion enhances therapeutic anti-cancer vaccination
Scott A. Fisher et al.
IMMUNITY INFLAMMATION AND DISEASE (2017)
Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia
L. Falchi et al.
ANNALS OF ONCOLOGY (2016)
T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression
Scott J. Patterson et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Target Density, Not Affinity or Avidity of Antigen Recognition, Determines Adoptive T Cell Therapy Outcomes in a Mouse Lymphoma Model
Gabriela Segal et al.
JOURNAL OF IMMUNOLOGY (2016)
Repeated Long-Term DT Application in the DEREG Mouse Induces a Neutralizing Anti-DT Antibody Response
Junhua Wang et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia
Fabienne McClanahan et al.
BLOOD (2015)
Enhanced suppressor function of TIM-3+FoxP3+ regulatory T cells
Anne-Sophie Gautron et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2014)
Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses
Nicole Joller et al.
IMMUNITY (2014)
The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia
Davide Brusa et al.
HAEMATOLOGICA (2013)
Rapid Deletion and Inactivation of CTLs upon Recognition of a Number of Target Cells over a Critical Threshold
Sandro Prato et al.
JOURNAL OF IMMUNOLOGY (2013)
How to calculate sample size in animal studies?
Jaykaran Charan et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2013)
CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia
Mariela Sivina et al.
BLOOD (2011)
Conditional Regulatory T-Cell Depletion Releases Adaptive Immunity Preventing Carcinogenesis and Suppressing Established Tumor Growth
Michele W. L. Teng et al.
CANCER RESEARCH (2010)
Immune resistance orchestrated by the tumor microenvironment
Thomas F. Gajewski et al.
IMMUNOLOGICAL REVIEWS (2006)
Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia
Amy J. Johnson et al.
BLOOD (2006)
Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression
R Bichi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
